Literature DB >> 2283163

Non-CS pre-erythrocytic protective antigens.

M R Hollingdale1, M Aikawa, C T Atkinson, W R Ballou, G X Chen, J Li, J F Meis, B Sina, C Wright, J D Zhu.   

Abstract

Three novel non-CS antigens have been identified on P. falciparum and P. berghei sporozoites and exoerythrocytic parasites. CSP-2 is a sporozoite surface protein common to P. falciparum and P. berghei that elicits antibody-mediated protection, and is also found within P. berghei EE parasites. LSA is a P. falciparum EE-specific antigen localized within the parasitophorous vacuole. LSA-2 is a P. berghei EE-specific antigen, localized on the parasitophorous vacuole membrane, that protected mice to P. berghei sporozoite challenge, and elicited cytotoxic T cells that killed P. berghei EE parasites in vitro.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2283163     DOI： 10.1016/0165-2478(90)90094-7

Source DB:  PubMed          Journal:  Immunol Lett        ISSN： 0165-2478            Impact factor:   3.685


  17 in total

1.  Pre-erythrocytic stage malaria parasites: non-circumsporozoite protein antigens.

Authors:  M R Hollingdale; M Aikawa; G X Chen; J F Meis; K Sakhuja; B Sina; J D Zhu
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.

Authors:  M B Joshi; A A Gam; R A Boykins; S Kumar; J Sacci; S L Hoffman; H L Nakhasi; R T Kenney
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Mouse model for exoerythrocytic stages of Plasmodium falciparum malaria parasite.

Authors:  J B Sacci; M E Schriefer; J H Resau; R A Wirtz; L J Detolla; R B Markham; A F Azad
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites.

Authors:  Sebastian A Mikolajczak; John B Sacci; Patricia De La Vega; Nelly Camargo; Kelly VanBuskirk; Urszula Krzych; Jun Cao; Marcelo Jacobs-Lorena; Alan F Cowman; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2011-06-24       Impact factor: 3.715

Review 5.  Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design.

Authors:  Javier E Garcia; Alvaro Puentes; Manuel E Patarroyo
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

6.  Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum.

Authors:  Collette J Hillier; Lisa A Ware; Arnoldo Barbosa; Evelina Angov; Jeffrey A Lyon; D Gray Heppner; David E Lanar
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.

Authors:  P Ray; N Sahoo; B Singh; F A Kironde
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

Review 8.  Malaria vaccines.

Authors:  R Amador; M E Patarroyo
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

9.  Expression of members of the heat-shock protein 70 family in the exoerythrocytic stages of Plasmodium berghei and Plasmodium falciparum.

Authors:  N Kumar; H Nagasawa; J B Sacci; B J Sina; M Aikawa; C Atkinson; P Uparanukraw; L B Kubiak; A F Azad; M R Hollingdale
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

10.  Expression, purification, and characterization of the immunological response to a 40-kilodalton Plasmodium vivax tryptophan-rich antigen.

Authors:  Asim A Siddiqui; Hema Bora; Neeru Singh; Aditya P Dash; Yagya D Sharma
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.